双层多叶准直器在局部晚期肺癌放疗中对心脏亚结构的剂量学表现
结果显示D-CS计划在保持靶区覆盖与适形指数相当的前提下,显著降低左心室、肺动脉、左前降支、左回旋支及冠状动脉的剂量指标,且冠心病、慢性心衰、急性心脏事件及放射性肺炎的相对风险排序为D-CS < S-CS < S-WH。
要点
- 双层MLC避让计划显著降低左心室、肺动脉、左前降支、左回旋支及冠状动脉剂量。
- D-CS计划靶区覆盖与适形指数与S-WH计划相当。
- 心脏事件与放射性肺炎相对风险排序为D-CS < S-CS < S-WH。
核心结论
- 双层MLC系统在心脏亚结构避让计划中表现优于单层MLC系统,为局部晚期肺癌患者后续免疫治疗提供新机会。
研究设计与样本
- 为每例患者制定单层MLC全心脏优化计划(S-WH)、单层MLC心脏亚结构避让计划(S-CS)和双层MLC心脏亚结构避让计划(D-CS)。
- 评估冠心病、慢性心衰、急性心脏事件和放射性肺炎的相对风险,以及免疫系统有效剂量。
主要发现
- D-CS计划显著降低左心室、肺动脉、左前降支、左回旋支及冠状动脉的剂量指标,同时保持靶区覆盖并与S-WH计划适形指数相当。
- D-CS计划显著降低左心室V5Gy和左回旋支V15Gy,其他亚结构也获得显著程度剂量降低。
- 冠心病、慢性心衰、急性心脏事件和放射性肺炎的相对风险排序为D-CS < S-CS < S-WH计划。
- D-CS计划的免疫系统有效剂量在三种计划中显示最低风险。
关键数值与推荐
- D-CS计划显著降低左心室V5Gy和左回旋支V15Gy。
- 冠心病、慢性心衰、急性心脏事件和放射性肺炎的相对风险排序为D-CS < S-CS < S-WH计划。
临床怎么用
- 对局部晚期肺癌放疗,采用双层MLC心脏亚结构避让计划可在不牺牲靶区覆盖与适形度的情况下降低心脏亚结构剂量及心脏事件与放射性肺炎相对风险。
- 该技术可能为局部晚期肺癌患者后续免疫治疗创造机会。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aims to reduce the risk of cardiovascular incidents and radiation pneumonia (RP) by improving the dose distribution to cardiac substructures through the use of a dual-layer multileaf collimator (MLC) accelerator- VenusX. METHODS AND MATERIALS: Eighteen patients with advanced-stage lung cancer were selected for this study. The total lung, spinal cord, whole heart, and specific cardiac substructures (including the left ventricle [LV], pulmonary artery, left anterior descending artery, left circumflex artery [LCX], and coronary artery) were delineated as organs at risk and incorporated into the optimization process of the avoidance plan. Single-layer MLC plans optimized for the whole heart, referred to as S-WH plans (where WH denotes whole heart), were developed alongside single-layer MLC plans specifically designed to avoid cardiac substructures, known as S-CS plans (where CS denotes cardiac substructures). Additionally, dual-layer MLC avoidance plans, designated as D-CS plans, were created for each patient. We evaluated the relative risk of coronary artery disease, chronic heart failure, acute cardiac events, and RP, as well as the effective dose to the immune system. RESULTS: D-CS plans significantly reduced the dose metrics of LV, pulmonary artery, left anterior descending artery, LCX, and the coronary, while maintaining target coverage and achieving comparable conformity index to the S-WH plans. Additionally, the D-CS plans significantly decreased the volume receiving 5 Gy (V5Gy) for the LV and V15Gy of LCX, with other substructures also experiencing a notable degree of dose reduction. Furthermore, the relative risk of coronary artery disease, chronic heart failure, acute cardiac event, and RP is ranked as follows: D-CS < S-CS < S-WH plans. Effective dose to the immune system of the D-CS plans indicated the lowest risk among the 3 plans. CONCLUSIONS: The dual-layer MLC system demonstrated superior performance compared to the single-layer MLC system in CS-avoidance plans, providing new opportunities for subsequent immunotherapy in patients with locally advanced lung cancer.
引用
- Feng A, Duan Y, Yang Z, et al. Dosimetric Performance of Orthogonal Dual-Layer Multi-Leaf Collimator System on Locally Advanced Lung Cancer: Cardiac Substructures Sparing Plans. Adv Radiat Oncol. 2025. PMID: 41036186. doi:10.1016/j.adro.2025.101891
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。